Published in Munch Med Wochenschr on March 24, 1967
Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1984) 5.49
Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49
Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature (1981) 4.78
Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med (1990) 4.46
Genetics of the antibody response to dextran in mice. Science (1972) 4.37
Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature (1981) 4.19
Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med (1985) 3.54
Transcription of mouse kappa chain genes: implications for allelic exclusion. Proc Natl Acad Sci U S A (1980) 3.38
Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature (1991) 3.32
Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature (1986) 3.24
Rearrangement of genetic information may produce immunoglobulin diversity. Nature (1979) 2.84
B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78
Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity (1995) 2.56
Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol (1994) 2.45
Residues that mediate DNA binding of autoimmune antibodies. J Immunol (1993) 2.37
DNA between variable and joining gene segments of immunoglobulin kappa light chain is frequently retained in cells that rearrange the kappa locus. Proc Natl Acad Sci U S A (1982) 2.36
Genetic control of antibody variable regions. Cold Spring Harb Symp Quant Biol (1977) 2.35
The joining of V and J gene segments creates antibody diversity. Nature (1980) 2.28
Immunochemical analysis of the cross-reacting idiotypes of mouse myeloma proteins with anti-dextran activity and normal anti-dextran antibody. Proc Natl Acad Sci U S A (1973) 2.21
Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. Nature (1975) 2.01
Revising B cell receptors. J Exp Med (2000) 1.96
Ig H and L chain contributions to autoimmune specificities. J Immunol (1991) 1.96
Light chain replacement: a new model for antibody gene rearrangement. J Exp Med (1995) 1.90
Editors and editing of anti-DNA receptors. Immunity (2001) 1.90
The site and stage of anti-DNA B-cell deletion. Nature (1995) 1.87
Multiplicity of germline genes specifying a group of related mouse kappa chains with implications for the generation of immunoglobulin diversity. Nature (1979) 1.85
Editing disease-associated autoantibodies. Immunity (1997) 1.81
Mouse lambda-chain sequences. Proc Natl Acad Sci U S A (1973) 1.78
How immunoglobulin V kappa genes rearrange. J Immunol (1987) 1.68
Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol (1975) 1.68
Deletion and editing of B cells that express antibodies to DNA. J Immunol (1994) 1.62
A Shannon entropy analysis of immunoglobulin and T cell receptor. Mol Immunol (1997) 1.58
Light chain contribution to specificity in anti-DNA antibodies. J Immunol (1995) 1.39
Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J Exp Med (1999) 1.36
Structural patterns in anti-DNA antibodies from MRL/lpr mice. Cold Spring Harb Symp Quant Biol (1989) 1.35
The BALB/c secondary response to the Sb site of influenza virus hemagglutinin. Nonrandom silent mutation and unequal numbers of VH and Vk mutations. J Immunol (1990) 1.30
Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med (1994) 1.29
Chromosomal locations of mouse immunoglobulin genes. Proc Natl Acad Sci U S A (1978) 1.29
Immunoglobulins with hapten-binding activity: structure-function correlations and genetic implications. Eur J Immunol (1978) 1.22
Mouse immunoglobulin heavy chains are coded by multiple germ line variable region genes. Proc Natl Acad Sci U S A (1974) 1.22
New methods for the treatment of lunatomalacia. Reconstr Surg Traumatol (1969) 1.22
Immunochemical analysis of the idiotypes of mouse myeloma proteins with specificity for levan or dextran. J Exp Med (1974) 1.20
Heavy-chain class switch does not terminate somatic mutation. J Exp Med (1990) 1.16
Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci U S A (2001) 1.15
Origins of anti-DNA antibodies and their implications for B-cell tolerance. Ann N Y Acad Sci (1995) 1.15
Aberrant rearrangement of the kappa light-chain locus involving the heavy-chain locus and chromosome 15 in a mouse plasmacytoma. Nature (1983) 1.14
Reorganization and expression of immunoglobulin genes: status of allelic elements. Cold Spring Harb Symp Quant Biol (1981) 1.12
Genetics of mouse antibodies. II. Recombination between VH genes and allotype. Eur J Immunol (1975) 1.10
[Errors and hazards in total hip-joint prosthesis]. Z Orthop Ihre Grenzgeb (1971) 1.10
Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol (1992) 1.09
Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med (1998) 1.09
Antibody gene linkage studies in (NZB X C58) recombinant-inbred lines. J Immunol (1980) 1.09
Myeloma proteins from NZB and BALB/c mice: structural and functional differences. Proc Natl Acad Sci U S A (1979) 1.07
Genetic polymorphism at the kappa chain locus in mice: comparisons of restriction enzyme hybridization fragments of variable and constant region genes. Immunogenetics (1985) 1.02
Independent segregation of NZB immune abnormalities in NZB x C58 recombinant inbred mice. Eur J Immunol (1982) 1.02
[A possibility for the surgical therapy of acetabular protrusion]. Arch Orthop Unfallchir (1970) 1.00
[Simple procedure for the surgical management of habitual peroneal tendon luxation]. Z Orthop Ihre Grenzgeb (1968) 0.98
The idiotypes of V kappa 21 light chains. Ann Immunol (Paris) (1984) 0.97
Amplification of immunoglobulin lambda constant genes in populations of wild mice. Nature (1982) 0.96
[Conservative or surgical treatment of recent lower leg fractures?]. Munch Med Wochenschr (1965) 0.92
Replication pattern in XXY cells with fra(X). Hum Genet (1982) 0.92
[Stimulation of bone formation using electrical current]. Hefte Unfallheilkd (1973) 0.92
Expression of kappa chains of the V kappa 21 group in Mus musculus and related species. Mol Immunol (1981) 0.91
[Total alloarthroplasty following arthrodesis]. Z Orthop Ihre Grenzgeb (1971) 0.91
[Advances in the technique of arthrodesis of the hip]. Munch Med Wochenschr (1968) 0.90
A solution to the rheumatoid factor paradox: pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factors. J Immunol (1997) 0.89
[Chondromalacia patellae in the active sportsman]. Z Orthop Ihre Grenzgeb (1968) 0.89
[Potentials in bone on electric stimulation (author's transl)]. Z Orthop Ihre Grenzgeb (1973) 0.88
[Injuries of the knee ligaments: suture or plastic repair]. Arch Orthop Unfallchir (1972) 0.87
[The speed of nerve-conduction after micro-surgical suture of the tibial nerve of the rabbit (author's transl)]. Z Orthop Ihre Grenzgeb (1975) 0.87
Plasmacytomas of the NZB mouse. J Immunol (1978) 0.87
[The regression of neurological symptoms following intervertebral disk surgery]. Z Orthop Ihre Grenzgeb (1967) 0.86
[Injury of the distal tibiofibular syndesmosis, its diagnosis and treatment]. Z Orthop Ihre Grenzgeb (1967) 0.85
[The tenodesis of the peroneus muscle for the treatment of the chronic insufficiency of the lateral ligaments of the upper ankle joint (author's transl)]. Int Orthop (1980) 0.85
[A method of operative treatment of recurrent displacement of peroneal tendons]. Arch Orthop Unfallchir (1972) 0.84
Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer. J Assist Reprod Genet (2000) 0.84
[Operative treatment of knee arthrosis in the elderly (author's transl)]. MMW Munch Med Wochenschr (1974) 0.84
Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease. J Immunol (1995) 0.84
[Follow up study of intertrochanteric valgus osteotomy with medial displacement in cases of primary protrusio acetabuly (author's transl)]. Arch Orthop Unfallchir (1973) 0.83
The structural basis of antigenic determinants on V kappa 21 light chains. Mol Immunol (1981) 0.83
[Radius-shortening osteotomy in os lunatum malacia]. Munch Med Wochenschr (1967) 0.82
[Experience with Chiari pelvic osteotomy in the adult (author's transl)]. Z Orthop Ihre Grenzgeb (1973) 0.82
Fixing mismatches. Science (1998) 0.81
[Treatment of patellar chondropathy in the athlete]. Munch Med Wochenschr (1972) 0.81
[A method of operative treatment of chronic instability of the ankle joint (author's transl)]. Arch Orthop Unfallchir (1974) 0.81
[Results and complications following endoprosthesis operations on the hip]. Z Orthop Ihre Grenzgeb (1969) 0.80
[Fragment extirpation in olecranon fractures]. Z Orthop Ihre Grenzgeb (1966) 0.79
[Degeneration, rupture and regeneration of the Achilles tendon]. Z Orthop Ihre Grenzgeb (1966) 0.79
A complex translocation at the murine kappa light-chain locus. Mol Cell Biol (1987) 0.78
[Late results in hemialloarthroplasty of the hip (author's transl)]. Arch Orthop Unfallchir (1976) 0.78
[Arthrodesis of the wrist joint]. Zentralbl Chir (1975) 0.78
[Patellectomy and its late results]. Arch Orthop Unfallchir (1969) 0.77
[Diagnosis and treatment of lumbar intervertebral disk prolapse]. Z Orthop Ihre Grenzgeb (1966) 0.77